New TB Drugs Risk Becoming Ineffective If Misused, Lancet Report Warns

CIDRAP News: Report warns of rise in drug-resistant tuberculosis
“A new report warns that some of the incremental progress made in the global fight against tuberculosis (TB) could be lost with the emergence and spread of drug-resistant strains of the disease…” (Dall, 3/23).

Humanosphere: Emerging epidemic of multidrug-resistant TB ‘threatens decades of progress’
“…According to the report published in [The Lancet Respiratory Medicine] ahead of World TB Day (March 24), roughly one in five cases are now resistant to at least one major anti-TB drug. About five percent of all cases are considered ‘multidrug-resistant’ — to two vital first-line drugs, isoniazid and rifampicin — or ‘extensively drug-resistant’ — to fluoroquinolones and second-line injectable drugs as well…” (Lu, 3/23).

Inter Press Service: New Tuberculosis Drugs May Become Ineffective: Study
“…Multidrug-resistant tuberculosis reflects the meeting of an ancient and under-addressed disease — tuberculosis — with an emerging modern threat — antimicrobial resistance. The inappropriate use of antibiotics, including taking them without prescription or not following doctor’s orders closely is slowly rendering many antibiotics useless…” (Rowlands, 3/24).

VOA News: On World Tuberculosis Day, Doctors Warn Of New Drug-Resistant Bacteria
“…The report warns the new drugs must be prescribed as individually targeted treatments with clear dosing guidelines, to prevent further resistant TB strains from emerging…” (Ridgwell, 3/24).